COINN: Comparison of Continuous Versus Intermittent Enteral Nutrition in Critically Ill Patients.

Sponsor
Masaryk University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03573453
Collaborator
Brno University Hospital (Other)
300
1
2
35.2
8.5

Study Details

Study Description

Brief Summary

The purpose of the study is to compare continuous versus intermittent strategy for enteral nutrition. The study will examine if there is a difference in achieving nutritional delivery goals, tolerance and number of complications of enteral nutrition.

Condition or Disease Intervention/Treatment Phase
  • Other: enteral nutrition
N/A

Detailed Description

The study will commence following the Approval by The Ethics Research Committee. All patients admitted to our ICU from the 1st of June 2018 to the 31st of May 2019 will be enrolled after fulfilling the inclusion criteria and in the absence of any exclusion criteria. Informed consent will be requested. Enteral nutrition will be administered via nasogastric of orogastric tube. Patients will be randomised in 2 groups. In the group of patients receiving continuous feeding will be enteral nutrition administered via enteral feeding pump for at least 16 hours par day. In the group of patients receiving intermittent feeding will be enteral nutrition administered as 30-60minutes lasting bolus via enteral feeding pump 6 times per day. Following the administration of the bolus the patient will be placed for 30 minutes in semi-upright sitting position. Enteral nutrition requirement and composition will be standardised with the adoption of international guidelines. In 5 subsequent days from the enteral nutrition commencement will be examined if there is a difference in achieving energy and protein targets, tolerance and number of complications of enteral nutrition in between both groups. As achievement of energy and protein targets will be considered at least 80% of calculated values. The tolerance of enteral nutrition will be evaluated by the clinical examination of the abdomen, presence of diarrhoea, vomiting and the gastric residual volume of at least 0,5 liter. As the complications of enteral nutrition will be regarded the aspiration of gastric contents and ventilator associated pneumonia. Nutritional status parameters will be analysed. the length of hospital stay, ICU length of stay and 28-day mortality will be also monitored.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Continuous Versus Intermittent Enteral Nutrition in Critically Ill Patients. Effect on Energy and Protein Target Achievement, Tolerance and Incidence of Complications. Monocentric Prospective Randomised Study.
Actual Study Start Date :
Nov 25, 2018
Anticipated Primary Completion Date :
Nov 1, 2021
Anticipated Study Completion Date :
Nov 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intermittent

enteral nutrition will be administered via enteral feeding pump as 30-60minutes lasting bolus 6 times per day volume of initial bolus will be 80ml. The volume of bolus will be increased gradually according to tolerance, till the estimated target rate will be reached

Other: enteral nutrition
administration of enteral nutrition

Experimental: Continuous

enteral nutrition will be administered via enteral feeding pump for at least 16 hours par day initial rate will be 25ml/hour. The rate will be increased gradually according to tolerance, till the estimated target rate will be reached

Other: enteral nutrition
administration of enteral nutrition

Outcome Measures

Primary Outcome Measures

  1. Energy target [5 days from initiation of enteral nutrition]

    Daily assessment of energy intake in critically ill patients with enteral nutrition.Energy target will be achieved if at least 80% of calculated energy intake will be delivered.

Secondary Outcome Measures

  1. Protein target [5 days from initiation of enteral nutrition]

    Daily assessment of protein intake in critically ill patients with enteral nutrition.Protein target will be achieved if at least 80% of calculated protein intake will be delivered.

  2. Tolerance of enteral nutrition [5 days from initiation of enteral nutrition]

    Measurement of the gastric residual volume

  3. Tolerance of enteral nutrition [5 days from initiation of enteral nutrition]

    Incidence of diarrhoea

  4. Tolerance of enteral nutrition [5 days from initiation of enteral nutrition]

    Incidence of vomiting

  5. Complications of enteral nutrition [5 days from initiation of enteral nutrition]

    Incidence of aspiration and ventilator associated pneumonia

  6. Nutritional status [On admission and day 5 from initiation of enteral nutrition]

    Blood test : total serum protein test

  7. Nutritional status [On admission and day 5 from initiation of enteral nutrition]

    Blood test : albumin test

  8. Nutritional status [On admission and day 5 from initiation of enteral nutrition]

    Blood test : prealbumin test

Other Outcome Measures

  1. ICU and hospital length of stay [through study completion, an average of 3 weeks]

  2. 28-day mortality [28 days from randomisation]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age between 18 - 80 years

  • indication of enteral nutrition with nasogastric or orogastric tube

  • Nutrition Risk in the Critically Ill (NUTRIC) score ≥5

  • Body mass index between 18 - 50

  • mechanical ventilation expected for at least 72 hours

Exclusion Criteria:
  • upper gastrointestinal tract surgery in previous medical history

  • bowel obstruction

  • bowel ischemia

  • acute pancreatitis

  • severe diarrhoea (>1l/24hours)

  • gastrointestinal bleeding

  • short bowel syndrome

  • malabsorption syndrome in previous medical history

  • ongoing enteral nutrition on admission to ICU

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Brno and Masaryk University Brno Brno Czechia 62500

Sponsors and Collaborators

  • Masaryk University
  • Brno University Hospital

Investigators

  • Study Chair: Roman Gal, prof MD PhD, Masaryk University Brno

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Masaryk University
ClinicalTrials.gov Identifier:
NCT03573453
Other Study ID Numbers:
  • CT0012018
First Posted:
Jun 29, 2018
Last Update Posted:
Mar 3, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Masaryk University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 3, 2021